Tu1880 IMPACT OF OZANIMOD (OZA) ON C-X-C MOTIF CHEMOKINE LIGAND 9 (CXCL9) LEVELS AND THE ASSOCIATION WITH OZA EFFICACY IN PATIENTS (PTS) WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE (CD): RESULTS FROM THE PHASE 2 STEPSTONE STUDY